Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Expands By 68.3%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 74,400 shares, a growth of 68.3% from the October 31st total of 44,200 shares. Currently, 1.5% of the shares of the company are short sold. Based on an average daily volume of 25,900 shares, the days-to-cover ratio is presently 2.9 days.

BioRestorative Therapies Stock Performance

Shares of NASDAQ BRTX traded up $0.05 during midday trading on Friday, hitting $1.53. 4,837 shares of the company’s stock traded hands, compared to its average volume of 736,430. BioRestorative Therapies has a 1 year low of $1.03 and a 1 year high of $3.67. The stock has a market capitalization of $10.59 million, a price-to-earnings ratio of -1.00 and a beta of 63.40. The firm has a fifty day moving average of $1.60 and a 200 day moving average of $1.60.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The firm had revenue of $0.23 million during the quarter, compared to analyst estimates of $0.30 million. On average, equities analysts anticipate that BioRestorative Therapies will post -1.43 earnings per share for the current year.

Analyst Ratings Changes

Separately, Roth Mkm upped their price target on shares of BioRestorative Therapies from $15.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.